Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy.

Fife KH, Wu JW, Squires KE, Watts DH, Andersen JW, Brown DR.

J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):274-82. doi: 10.1097/QAI.0b013e3181a97be5.

2.
3.

The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents.

Shrestha S, Sudenga SL, Smith JS, Bachmann LH, Wilson CM, Kempf MC.

BMC Infect Dis. 2010 Oct 14;10:295. doi: 10.1186/1471-2334-10-295.

4.

Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study.

Moodley JR, Constant D, Hoffman M, Salimo A, Allan B, Rybicki E, Hitzeroth I, Williamson AL.

BMC Cancer. 2009 Aug 7;9:275. doi: 10.1186/1471-2407-9-275.

5.

Evaluation of HIV and highly active antiretroviral therapy on the natural history of human papillomavirus infection and cervical cytopathologic findings in HIV-positive and high-risk HIV-negative women.

Blitz S, Baxter J, Raboud J, Walmsley S, Rachlis A, Smaill F, Ferenczy A, Coutlée F, Hankins C, Money D; Canadian Women's HIV Study Group.

J Infect Dis. 2013 Aug 1;208(3):454-62. doi: 10.1093/infdis/jit181. Epub 2013 Apr 26.

PMID:
23624362
6.

Influence of HIV-1 and/or HIV-2 infection and CD4 count on cervical HPV DNA detection in women from Senegal, West Africa.

Hanisch RA, Sow PS, Toure M, Dem A, Dembele B, Toure P, Winer RL, Hughes JP, Gottlieb GS, Feng Q, Kiviat NB, Hawes SE; University of Washington-Dakar HIV and Cervical Cancer Study Group.

J Clin Virol. 2013 Dec;58(4):696-702. doi: 10.1016/j.jcv.2013.10.012. Epub 2013 Oct 18.

7.

The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women.

Minkoff H, Ahdieh L, Massad LS, Anastos K, Watts DH, Melnick S, Muderspach L, Burk R, Palefsky J.

AIDS. 2001 Nov 9;15(16):2157-64.

PMID:
11684935
8.

Human papilloma virus types in the oral and cervical mucosa of HIV-positive South African women prior to antiretroviral therapy.

Richter KL, van Rensburg EJ, van Heerden WF, Boy SC.

J Oral Pathol Med. 2008 Oct;37(9):555-9. doi: 10.1111/j.1600-0714.2008.00670.x. Epub 2008 Mar 19.

PMID:
18355174
9.

Human papillomavirus infection and cervical abnormalities in Nairobi, Kenya, an area with a high prevalence of human immunodeficiency virus infection.

Yamada R, Sasagawa T, Kirumbi LW, Kingoro A, Karanja DK, Kiptoo M, Nakitare GW, Ichimura H, Inoue M.

J Med Virol. 2008 May;80(5):847-55. doi: 10.1002/jmv.21170.

PMID:
18360898
10.

HIV-1 seroconversion promotes rapid changes in cervical human papillomavirus (HPV) prevalence and HPV-16 antibodies in female sex workers.

Marais DJ, Carrara H, Ramjee G, Kay P, Williamson AL.

J Med Virol. 2009 Feb;81(2):203-10. doi: 10.1002/jmv.21343.

PMID:
19107974
11.

Human papillomavirus detection in women with and without human immunodeficiency virus infection in Colombia.

Camargo M, Soto-De Leon SC, Munoz M, Sanchez R, Peña-Herrera D, Pineda-Peña AC, Sussmann O, Paez C, Perez-Prados A, Patarroyo ME, Patarroyo MA.

BMC Cancer. 2014 Jun 18;14:451. doi: 10.1186/1471-2407-14-451.

12.

HPV infection in HIV-positive females: the need for cervical cancer screening including HPV-DNA detection despite successful HAART.

Madeddu G, Mameli G, Capobianco G, Babudieri S, Maida I, Bagella P, Rocca G, Cherchi PL, Sechi LA, Zanetti S, Nunnari G, Dessole S, Mura MS.

Eur Rev Med Pharmacol Sci. 2014;18(8):1277-85.

13.

Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women.

Konopnicki D, Manigart Y, Gilles C, Barlow P, de Marchin J, Feoli F, Larsimont D, Delforge M, De Wit S, Clumeck N.

J Infect Dis. 2013 Jun 1;207(11):1723-9. doi: 10.1093/infdis/jit090. Epub 2013 Mar 5.

PMID:
23463709
14.

Prevalence of and Risk Factors for Anal Oncogenic Human Papillomavirus Infection Among HIV-Infected Women in France in the Combination Antiretroviral Therapy Era.

Heard I, Poizot-Martin I, Potard V, Etienney I, Crenn-Hebert C, Moore C, Touraine P, Cubie H, Costagliola D; ANRS-C017 VIHGY Study Group.

J Infect Dis. 2016 May 1;213(9):1455-61. doi: 10.1093/infdis/jiv751. Epub 2015 Dec 21.

PMID:
26690345
15.

Combination antiretroviral therapy reduces the detection risk of cervical human papilloma virus infection in women living with HIV.

Zeier MD, Botha MH, Engelbrecht S, Machekano RN, Jacobs GB, Isaacs S, van Schalkwyk M, van der Merwe H, Mason D, Nachega JB.

AIDS. 2015 Jan 2;29(1):59-66. doi: 10.1097/QAD.0000000000000512.

PMID:
25387313
16.

HIV-1, HIV-2, human papillomavirus infection and cervical neoplasia in high-risk African women.

Langley CL, Benga-De E, Critchlow CW, Ndoye I, Mbengue-Ly MD, Kuypers J, Woto-Gaye G, Mboup S, Bergeron C, Holmes KK, Kiviat NB.

AIDS. 1996 Apr;10(4):413-7.

PMID:
8728046
17.

Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy.

Lillo FB, Ferrari D, Veglia F, Origoni M, Grasso MA, Lodini S, Mastrorilli E, Taccagni G, Lazzarin A, Uberti-Foppa C.

J Infect Dis. 2001 Sep 1;184(5):547-51. Epub 2001 Aug 9.

PMID:
11494160
18.

The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology.

Paramsothy P, Jamieson DJ, Heilig CM, Schuman PC, Klein RS, Shah KV, Rompalo AM, Cu-Uvin S, Duerr A.

Obstet Gynecol. 2009 Jan;113(1):26-31. doi: 10.1097/AOG.0b013e31819225cb.

PMID:
19104356
19.

High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral shedding.

Theiler RN, Farr SL, Karon JM, Paramsothy P, Viscidi R, Duerr A, Cu-Uvin S, Sobel J, Shah K, Klein RS, Jamieson DJ.

Obstet Gynecol. 2010 Jun;115(6):1150-8. doi: 10.1097/AOG.0b013e3181e00927.

PMID:
20502284
20.

Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study).

Kojic EM, Cu-Uvin S, Conley L, Bush T, Onyekwuluje J, Swan DC, Unger ER, Henry K, Hammer JH, Overton ET, Darragh TM, Palefsky JM, Vellozzi C, Patel P, Brooks JT.

Sex Transm Dis. 2011 Apr;38(4):253-9. doi: 10.1097/OLQ.0b013e3181f70253.

PMID:
20966828

Supplemental Content

Support Center